Screener
Viridian Therapeutics, Inc. VRDN Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Marketable securities | 816,544 | 662,270 |
| Other receivable | 75,000 | — |
| Prepaid expenses and other current assets | 24,740 | 19,581 |
| Total current assets | 1,081,270 | 894,233 |
| Property and equipment, net | 2,765 | 1,228 |
| Operating lease right-of-use asset | 2,085 | 2,421 |
| Intangible asset, net | 10,000 | — |
| Other assets | 1,113 | 1,536 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s total current assets?
- Viridian Therapeutics, Inc. (VRDN) reported total current assets of $1.08B in Q2 2026.
- How has Viridian Therapeutics, Inc.'s total current assets changed year-over-year?
- Viridian Therapeutics, Inc.'s total current assets increased by 86.8% year-over-year, from $578.75M to $1.08B.
- What is the long-term trend for Viridian Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s total current assets has grown at a 47.2% compound annual growth rate (CAGR), from $129.61M to $894.23M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Viridian Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude